SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration

BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.

Subsidie
€ 4.039.541
2022

Projectdetails

Introduction

Reconstructive surgeries frequently require multiple, often complex, procedures at high social and economic costs. A shape-morphing implant that can be implanted using less invasive procedures and that then undergoes predesigned shape changes, leading to tissue expansion and allowing for complete degradation coupled with tissue regeneration, is a radically new treatment concept.

Project Goals

BIOMET4D aims to create a new generation of shape-shifting and load-bearing implants for dynamic tissue restoration and to introduce a revolutionary paradigm in how actuators can be implemented in biomedicine.

Technological Innovations

Science-towards-technology breakthroughs will be demonstrated with:

  1. New shape-morphing metamaterials
  2. 4D smart metallic actuators
  3. Advanced multi-domain optimization tools
  4. Proof-of-concept for two potential clinical applications

Technologically, this vision also goes beyond existing paradigms because of the step-by-step actuation mechanisms, enabled through the additive manufacturing of multi-material degradable metallic structures, that are targeted for an order of magnitude improvement compared to the state-of-the-art.

Long-term Vision

A futuristic long-term vision of this breakthrough technology is to dynamically regenerate entire tissues, such as a nose or an ear. Proof-of-concept will be demonstrated for:

  • Craniosynostosis treatment
  • Skin expansion

This long-term vision can only be achieved through an interdisciplinary approach and will likely have high social and economic impact as well as provide a new line of research for applications of smart metamaterials in medicine and engineering.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 4.039.541
Totale projectbegroting€ 4.039.541

Tijdlijn

Startdatum1-7-2022
Einddatum30-6-2026
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • FUNDACION IMDEA MATERIALESpenvoerder
  • UNIVERSIDAD POLITECNICA DE MADRID
  • SCHAEFFLER AEROSINT
  • MEOTEC GMBH
  • KLINIKUM DER UNIVERSITAET ZU KOELN
  • UNIVERSITY OF GALWAY
  • FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANON
  • UNIVERSITAETSKLINIKUM AACHEN
  • AMAZEMET SP. Z O.O.

Land(en)

SpainBelgiumGermanyIrelandPoland

Inhoudsopgave

EIC Pathfinder

Financiering tot €3–4 mln voor high‑risk, high‑gain onderzoek naar baanbrekende technologieën binnen Horizon Europe.

Bekijk regeling

Vergelijkbare projecten binnen EIC Pathfinder

ProjectRegelingBedragJaarActie

Biointegrable soft actuators alimented by metabolic energy

INTEGRATE aims to revolutionize implantable devices by using metabolic energy to power 3D-printed soft actuating materials and an energy-harvesting organ, enhancing autonomy and efficiency.

EIC Pathfinder€ 1.698.750
2022
Details

Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord

Piezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy.

EIC Pathfinder€ 3.537.120
2023
Details

Bacteria Biofilm as bio-factory for tissue regeneration

BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.

EIC Pathfinder€ 2.903.862
2023
Details

building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans

THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.

EIC Pathfinder€ 3.994.150
2023
Details

Bioinspired cellular actuators

BiCeps aims to create robust, muscle-inspired actuators using multi-material additive manufacturing to revolutionize mechanical motion and replace traditional motors across various sectors.

EIC Pathfinder€ 2.894.306
2025
Details
EIC Pathfinder

Biointegrable soft actuators alimented by metabolic energy

INTEGRATE aims to revolutionize implantable devices by using metabolic energy to power 3D-printed soft actuating materials and an energy-harvesting organ, enhancing autonomy and efficiency.

EIC Pathfinder
€ 1.698.750
2022
Details
EIC Pathfinder

Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord

Piezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy.

EIC Pathfinder
€ 3.537.120
2023
Details
EIC Pathfinder

Bacteria Biofilm as bio-factory for tissue regeneration

BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.

EIC Pathfinder
€ 2.903.862
2023
Details
EIC Pathfinder

building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans

THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.

EIC Pathfinder
€ 3.994.150
2023
Details
EIC Pathfinder

Bioinspired cellular actuators

BiCeps aims to create robust, muscle-inspired actuators using multi-material additive manufacturing to revolutionize mechanical motion and replace traditional motors across various sectors.

EIC Pathfinder
€ 2.894.306
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

ERC Starting...€ 1.499.906
2023
Details

Dynamic control of Gaussian morphing structures via embedded fluidic networks

The project aims to create fully controllable shape-morphing materials using hybrid elastic plates with fluid-filled cavities, enabling precise programming of shape, mechanics, and deformation dynamics for biomedical applications.

ERC Starting...€ 1.499.601
2025
Details

Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds

MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.

ERC Starting...€ 1.495.288
2024
Details

Morphing tubular structures for adaptive biomedical devices

Stripe-oMorph aims to develop adaptable, bio-inspired morphing tubular structures for interventional medical devices, enhancing their compatibility with complex geometries and patient-specific needs.

ERC Proof of...€ 150.000
2022
Details

Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing

ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.

ERC Proof of...€ 150.000
2023
Details
ERC Starting...

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

ERC Starting Grant
€ 1.499.906
2023
Details
ERC Starting...

Dynamic control of Gaussian morphing structures via embedded fluidic networks

The project aims to create fully controllable shape-morphing materials using hybrid elastic plates with fluid-filled cavities, enabling precise programming of shape, mechanics, and deformation dynamics for biomedical applications.

ERC Starting Grant
€ 1.499.601
2025
Details
ERC Starting...

Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds

MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.

ERC Starting Grant
€ 1.495.288
2024
Details
ERC Proof of...

Morphing tubular structures for adaptive biomedical devices

Stripe-oMorph aims to develop adaptable, bio-inspired morphing tubular structures for interventional medical devices, enhancing their compatibility with complex geometries and patient-specific needs.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Proof of...

Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing

ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.

ERC Proof of Concept
€ 150.000
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.